(S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of ITGB5 mRNA CTD PMID:20426880 1,2-dimethylhydrazine multiple interactions ISO RGD:1617621 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ITGB5 mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO RGD:1617621 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ITGB5 mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression ISO RGD:1617621 6480464 Ethinyl Estradiol affects the expression of ITGB5 mRNA CTD PMID:17555576 17alpha-ethynylestradiol decreases expression ISO RGD:1617621 6480464 Ethinyl Estradiol results in decreased expression of ITGB5 mRNA CTD PMID:17942748 17beta-estradiol multiple interactions ISO RGD:1349145 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of ITGB5 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ITGB5 mRNA CTD PMID:19490992 more ... 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1617621 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in decreased expression of ITGB5 mRNA, Tetrachlorodibenzodioxin affects the reaction [AHR protein binds to ITGB5 promoter] CTD PMID:17942748 , PMID:19654925 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1617621 6480464 Tetrachlorodibenzodioxin affects the expression of ITGB5 mRNA CTD PMID:21570461 2-hydroxypropanoic acid decreases expression ISO RGD:1349145 6480464 Lactic Acid results in decreased expression of ITGB5 mRNA CTD PMID:30851411 2-methylcholine affects expression ISO RGD:1349145 6480464 beta-methylcholine affects the expression of ITGB5 mRNA CTD PMID:21179406 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3,3',5-triiodo-L-thyronine increases expression ISO RGD:1349145 6480464 Triiodothyronine results in increased expression of ITGB5 mRNA CTD PMID:23397585 3,3',5-triiodo-L-thyronine decreases expression ISO RGD:1349145 6480464 Triiodothyronine results in decreased expression of ITGB5 mRNA CTD PMID:23397585 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1617621 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of ITGB5 mRNA CTD PMID:20188158 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1349145 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ITGB5 mRNA CTD PMID:28628672 3-methylcholanthrene decreases expression ISO RGD:1349145 6480464 Methylcholanthrene results in decreased expression of ITGB5 mRNA CTD PMID:23397585 4,4'-sulfonyldiphenol increases expression ISO RGD:1617621 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ITGB5 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol affects methylation ISO RGD:1617621 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of ITGB5 gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases expression ISO RGD:1349145 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of ITGB5 protein CTD PMID:34186270 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1617621 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of ITGB5 exon CTD PMID:33297965 4-hydroxyphenyl retinamide decreases expression ISO RGD:1617621 6480464 Fenretinide results in decreased expression of ITGB5 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO RGD:1349145 6480464 Decitabine affects the expression of ITGB5 mRNA CTD PMID:23300844 6-propyl-2-thiouracil decreases expression ISO RGD:1349145 6480464 Propylthiouracil results in decreased expression of ITGB5 mRNA CTD PMID:23397585 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ITGB5 mRNA CTD PMID:24780913 , PMID:30047161 acrolein multiple interactions ISO RGD:1349145 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ITGB5 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ITGB5 mRNA CTD PMID:32699268 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of ITGB5 mRNA CTD PMID:33354967 all-trans-retinoic acid multiple interactions ISO RGD:1617621 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ITGB5 mRNA CTD PMID:30951980 alpha-pinene multiple interactions ISO RGD:1349145 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ITGB5 mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased oxidation of ITGB5 mRNA CTD PMID:32699268 amiodarone decreases expression ISO RGD:1349145 6480464 Amiodarone results in decreased expression of ITGB5 mRNA CTD PMID:23397585 amitrole decreases expression ISO RGD:1349145 6480464 Amitrole results in decreased expression of ITGB5 mRNA CTD PMID:23397585 amitrole decreases expression EXP 6480464 Amitrole results in decreased expression of ITGB5 mRNA CTD PMID:30047161 antirheumatic drug increases expression ISO RGD:1349145 6480464 Antirheumatic Agents results in increased expression of ITGB5 mRNA CTD PMID:24449571 Aroclor 1254 decreases expression ISO RGD:1617621 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of ITGB5 mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:1349145 6480464 Arsenic affects the methylation of ITGB5 gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1349145 6480464 Arsenic affects the methylation of ITGB5 gene CTD PMID:25304211 belinostat decreases expression ISO RGD:1349145 6480464 belinostat results in decreased expression of ITGB5 mRNA CTD PMID:26272509 benzene decreases expression ISO RGD:1349145 6480464 Benzene results in decreased expression of ITGB5 mRNA CTD PMID:19162166 benzo[a]pyrene multiple interactions ISO RGD:1617621 6480464 Benzo(a)pyrene affects the reaction [AHR protein binds to ITGB5 promoter] CTD PMID:19654925 benzo[a]pyrene decreases expression ISO RGD:1617621 6480464 Benzo(a)pyrene results in decreased expression of ITGB5 mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1617621 6480464 Benzo(a)pyrene results in increased expression of ITGB5 mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1349145 6480464 7 more ... CTD PMID:19150397 bis(2-chloroethyl) sulfide multiple interactions ISO RGD:1617621 6480464 Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of ITGB5 mRNA] CTD PMID:16377760 bis(2-chloroethyl) sulfide decreases expression ISO RGD:1617621 6480464 Mustard Gas results in decreased expression of ITGB5 mRNA CTD PMID:16377760 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ITGB5 mRNA CTD PMID:25181051 bisphenol A increases expression ISO RGD:1349145 6480464 bisphenol A results in increased expression of ITGB5 protein CTD PMID:34186270 bisphenol A decreases methylation ISO RGD:1349145 6480464 bisphenol A results in decreased methylation of ITGB5 gene CTD PMID:31601247 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ITGB5 mRNA CTD PMID:34947998 bisphenol A increases expression ISO RGD:1617621 6480464 bisphenol A results in increased expression of ITGB5 mRNA CTD PMID:30951980 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ITGB5 gene CTD PMID:28505145 Bisphenol B increases expression ISO RGD:1349145 6480464 bisphenol B results in increased expression of ITGB5 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:1349145 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ITGB5 mRNA CTD PMID:28628672 bisphenol F increases expression ISO RGD:1349145 6480464 bisphenol F results in increased expression of ITGB5 protein CTD PMID:34186270 bisphenol F multiple interactions ISO RGD:1617621 6480464 [bisphenol F co-treated with Tretinoin] results in decreased expression of ITGB5 mRNA CTD PMID:30951980 bisphenol F increases expression ISO RGD:1617621 6480464 bisphenol F results in increased expression of ITGB5 mRNA CTD PMID:30951980 bleomycin A5 increases expression ISO RGD:1349145 6480464 bleomycetin results in increased expression of ITGB5 mRNA CTD PMID:21040473 cadmium dichloride decreases expression ISO RGD:1349145 6480464 Cadmium Chloride results in decreased expression of ITGB5 mRNA CTD PMID:23397585 carbamazepine affects expression ISO RGD:1349145 6480464 Carbamazepine affects the expression of ITGB5 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO RGD:1617621 6480464 Nanotubes, Carbon analog results in decreased expression of ITGB5 mRNA CTD PMID:25554681 ciglitazone multiple interactions ISO RGD:1349145 6480464 [ciglitazone binds to PPARG protein] which results in increased expression of ITGB5 mRNA CTD PMID:16197558 cisplatin decreases expression ISO RGD:1617621 6480464 Cisplatin results in decreased expression of ITGB5 mRNA CTD PMID:21151649 cisplatin affects expression ISO RGD:1349145 6480464 Cisplatin affects the expression of ITGB5 mRNA CTD PMID:23300844 clofibrate decreases expression ISO RGD:1617621 6480464 Clofibrate results in decreased expression of ITGB5 mRNA CTD PMID:17585979 cobalt dichloride increases expression ISO RGD:1349145 6480464 cobaltous chloride results in increased expression of ITGB5 mRNA CTD PMID:19376846 cobalt dichloride decreases expression EXP 6480464 cobaltous chloride results in decreased expression of ITGB5 mRNA CTD PMID:24386269 cobalt dichloride decreases expression ISO RGD:1349145 6480464 cobaltous chloride results in decreased expression of ITGB5 mRNA CTD PMID:19376846 cocaine affects expression EXP 6480464 Cocaine affects the expression of ITGB5 mRNA CTD PMID:20187946 colforsin daropate hydrochloride increases expression ISO RGD:1349145 6480464 Colforsin results in increased expression of ITGB5 mRNA CTD PMID:16751804 copper atom multiple interactions ISO RGD:1617621 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ITGB5 mRNA CTD PMID:15467011 copper atom multiple interactions ISO RGD:1349145 6480464 [Chelating Agents binds to Copper] which affects the expression of ITGB5 mRNA, [Disulfiram binds to Copper] which results in increased expression of ITGB5 mRNA CTD PMID:24690739 , PMID:30911355 copper(0) multiple interactions ISO RGD:1617621 6480464 [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of ITGB5 mRNA CTD PMID:15467011 copper(0) multiple interactions ISO RGD:1349145 6480464 [Chelating Agents binds to Copper] which affects the expression of ITGB5 mRNA, [Disulfiram binds to Copper] which results in increased expression of ITGB5 mRNA CTD PMID:24690739 , PMID:30911355 copper(II) sulfate increases expression ISO RGD:1349145 6480464 Copper Sulfate results in increased expression of ITGB5 mRNA CTD PMID:19549813 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of ITGB5 mRNA CTD PMID:26577399 cytarabine decreases expression ISO RGD:1349145 6480464 Cytarabine results in decreased expression of ITGB5 mRNA CTD PMID:21198554 dabrafenib multiple interactions ISO RGD:1349145 6480464 dabrafenib inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of [ITGAV protein binds to ITGB5 protein]] CTD PMID:29042256 dexamethasone increases expression ISO RGD:1617621 6480464 Dexamethasone results in increased expression of ITGB5 mRNA CTD PMID:21041162 dexamethasone multiple interactions ISO RGD:1349145 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ITGB5 mRNA CTD PMID:28628672 dimercaprol multiple interactions ISO RGD:1617621 6480464 Dimercaprol inhibits the reaction [Mustard Gas results in decreased expression of ITGB5 mRNA] CTD PMID:16377760 disulfiram multiple interactions ISO RGD:1349145 6480464 [Disulfiram binds to Copper] which results in increased expression of ITGB5 mRNA CTD PMID:24690739 dorsomorphin multiple interactions ISO RGD:1349145 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:1349145 6480464 Doxorubicin results in increased expression of ITGB5 mRNA CTD PMID:29803840 entinostat multiple interactions ISO RGD:1349145 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ITGB5 mRNA CTD PMID:27188386 entinostat decreases expression ISO RGD:1349145 6480464 entinostat results in decreased expression of ITGB5 mRNA CTD PMID:26272509 enzacamene decreases expression ISO RGD:1349145 6480464 enzacamene results in decreased expression of ITGB5 mRNA CTD PMID:23397585 enzacamene increases expression ISO RGD:1349145 6480464 enzacamene results in increased expression of ITGB5 mRNA CTD PMID:30597193 ethanol multiple interactions ISO RGD:1617621 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ITGB5 mRNA CTD PMID:30517762 ethanol increases expression ISO RGD:1617621 6480464 Ethanol results in increased expression of ITGB5 mRNA CTD PMID:30319688 ethanol multiple interactions ISO RGD:1349145 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ITGB5 mRNA CTD PMID:29432896 fenthion decreases expression ISO RGD:1617621 6480464 Fenthion results in decreased expression of ITGB5 mRNA CTD PMID:34813904 fenvalerate decreases expression ISO RGD:1349145 6480464 fenvalerate results in decreased expression of ITGB5 mRNA CTD PMID:23397585 folic acid multiple interactions ISO RGD:1617621 6480464 [1, 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of ITGB5 mRNA CTD PMID:22206623 glyphosate decreases expression ISO RGD:1349145 6480464 glyphosate results in decreased expression of ITGB5 mRNA CTD PMID:31295307 hydrogen peroxide decreases expression ISO RGD:1349145 6480464 Hydrogen Peroxide results in decreased expression of ITGB5 mRNA CTD PMID:12419474 hydrogen peroxide increases expression ISO RGD:1349145 6480464 Hydrogen Peroxide results in increased expression of ITGB5 mRNA CTD PMID:18951874 hypochlorous acid decreases expression ISO RGD:1617621 6480464 Hypochlorous Acid results in decreased expression of ITGB5 mRNA CTD PMID:19376150 indometacin multiple interactions ISO RGD:1349145 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ITGB5 mRNA CTD PMID:28628672 indometacin decreases expression EXP 6480464 Indomethacin results in decreased expression of ITGB5 mRNA CTD PMID:36868495 Iopanoic acid decreases expression ISO RGD:1349145 6480464 Iopanoic Acid results in decreased expression of ITGB5 mRNA CTD PMID:23397585 isobutanol multiple interactions ISO RGD:1349145 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of ITGB5 mRNA CTD PMID:29432896 ivermectin decreases expression ISO RGD:1349145 6480464 Ivermectin results in decreased expression of ITGB5 protein CTD PMID:32959892 lead diacetate increases expression ISO RGD:1617621 6480464 lead acetate results in increased expression of ITGB5 mRNA CTD PMID:22609695 lipopolysaccharide multiple interactions ISO RGD:1349145 6480464 [NAT10 protein affects the susceptibility to Lipopolysaccharides] which affects the expression of ITGB5 mRNA CTD PMID:35877022 manganese atom increases expression ISO RGD:1349145 6480464 Manganese results in increased expression of ITGB5 mRNA CTD PMID:17175027 manganese(0) increases expression ISO RGD:1349145 6480464 Manganese results in increased expression of ITGB5 mRNA CTD PMID:17175027 manganese(II) chloride increases expression ISO RGD:1349145 6480464 manganese chloride results in increased expression of ITGB5 mRNA CTD PMID:17175027 medroxyprogesterone acetate decreases expression ISO RGD:1349145 6480464 Medroxyprogesterone Acetate results in decreased expression of ITGB5 mRNA CTD PMID:18497975 methidathion decreases expression ISO RGD:1617621 6480464 methidathion results in decreased expression of ITGB5 mRNA CTD PMID:34813904 methimazole increases expression ISO RGD:1349145 6480464 Methimazole results in increased expression of ITGB5 mRNA CTD PMID:23397585 methimazole decreases expression EXP 6480464 Methimazole results in decreased expression of ITGB5 mRNA CTD PMID:30047161 methoxychlor decreases expression ISO RGD:1349145 6480464 Methoxychlor results in decreased expression of ITGB5 mRNA CTD PMID:23397585 methylparaben decreases expression ISO RGD:1349145 6480464 methylparaben results in decreased expression of ITGB5 mRNA CTD PMID:31745603 methylseleninic acid decreases expression ISO RGD:1349145 6480464 methylselenic acid results in decreased expression of ITGB5 mRNA CTD PMID:12517777 nickel atom decreases expression ISO RGD:1349145 6480464 Nickel results in decreased expression of ITGB5 mRNA CTD PMID:25583101 nicotine increases expression EXP 6480464 Nicotine results in increased expression of ITGB5 mRNA CTD PMID:20426880 ozone multiple interactions ISO RGD:1349145 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased oxidation of ITGB5 mRNA more ... CTD PMID:32699268 ozone multiple interactions ISO RGD:1617621 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of ITGB5 mRNA CTD PMID:34911549 paclitaxel decreases response to substance ISO RGD:1349145 6480464 ITGB5 mRNA results in decreased susceptibility to Paclitaxel CTD PMID:16322897 panobinostat decreases expression ISO RGD:1349145 6480464 panobinostat results in decreased expression of ITGB5 mRNA CTD PMID:26272509 panobinostat multiple interactions ISO RGD:1349145 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ITGB5 mRNA CTD PMID:27188386 paracetamol decreases expression ISO RGD:1349145 6480464 Acetaminophen results in decreased expression of ITGB5 mRNA CTD PMID:21420995 phenylmercury acetate decreases expression ISO RGD:1349145 6480464 Phenylmercuric Acetate results in decreased expression of ITGB5 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO RGD:1349145 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ITGB5 mRNA CTD PMID:27188386 pirinixic acid decreases expression ISO RGD:1617621 6480464 pirinixic acid results in decreased expression of ITGB5 mRNA CTD PMID:17426115 pregnenolone 16alpha-carbonitrile decreases expression EXP 6480464 Pregnenolone Carbonitrile results in decreased expression of ITGB5 mRNA CTD PMID:30047161 propiconazole decreases expression ISO RGD:1617621 6480464 propiconazole results in decreased expression of ITGB5 mRNA CTD PMID:21278054 rac-lactic acid decreases expression ISO RGD:1349145 6480464 Lactic Acid results in decreased expression of ITGB5 mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO RGD:1349145 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO RGD:1349145 6480464 Silicon Dioxide results in increased expression of ITGB5 mRNA CTD PMID:25351596 silicon dioxide decreases expression ISO RGD:1617621 6480464 Silicon Dioxide results in decreased expression of ITGB5 mRNA CTD PMID:29203145 sodium arsenite decreases expression ISO RGD:1617621 6480464 sodium arsenite results in decreased expression of ITGB5 mRNA CTD PMID:16014739 sodium arsenite decreases expression EXP 6480464 sodium arsenite results in decreased expression of ITGB5 mRNA CTD PMID:35314868 sodium dichromate decreases expression ISO RGD:1349145 6480464 sodium bichromate results in decreased expression of ITGB5 mRNA CTD PMID:17685462 sodium dichromate increases expression ISO RGD:1617621 6480464 sodium bichromate results in increased expression of ITGB5 mRNA CTD PMID:31558096 succimer multiple interactions ISO RGD:1617621 6480464 [Succimer binds to Magnetite Nanoparticles] which results in decreased expression of ITGB5 mRNA CTD PMID:21641980 succimer multiple interactions ISO RGD:1349145 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of ITGB5 mRNA CTD PMID:26378955 sulfadimethoxine decreases expression EXP 6480464 Sulfadimethoxine results in decreased expression of ITGB5 mRNA CTD PMID:30047161 T-2 toxin decreases expression ISO RGD:1349145 6480464 T-2 Toxin results in decreased expression of ITGB5 mRNA CTD PMID:31863870 tamoxifen affects expression ISO RGD:1617621 6480464 Tamoxifen affects the expression of ITGB5 mRNA CTD PMID:17555576 tert-butyl hydroperoxide decreases expression ISO RGD:1349145 6480464 tert-Butylhydroperoxide results in decreased expression of ITGB5 mRNA CTD PMID:12419474 tetrachloromethane affects expression ISO RGD:1617621 6480464 Carbon Tetrachloride affects the expression of ITGB5 mRNA CTD PMID:17484886 tetrachloromethane multiple interactions ISO RGD:1617621 6480464 [Carbon Tetrachloride co-treated with Ethanol] results in increased expression of ITGB5 mRNA CTD PMID:30517762 tetrachloromethane increases expression ISO RGD:1617621 6480464 Carbon Tetrachloride results in increased expression of ITGB5 mRNA CTD PMID:25827057 thapsigargin decreases expression ISO RGD:1617621 6480464 Thapsigargin results in decreased expression of ITGB5 protein CTD PMID:24648495 topotecan increases expression EXP 6480464 Topotecan results in increased expression of ITGB5 mRNA CTD PMID:25729387 trichostatin A decreases expression ISO RGD:1349145 6480464 trichostatin A results in decreased expression of ITGB5 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:1349145 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ITGB5 mRNA CTD PMID:27188386 triclosan decreases expression ISO RGD:1349145 6480464 Triclosan results in decreased expression of ITGB5 mRNA CTD PMID:30510588 trovafloxacin decreases expression ISO RGD:1617621 6480464 trovafloxacin results in decreased expression of ITGB5 mRNA CTD PMID:35537566 valproic acid affects expression ISO RGD:1349145 6480464 Valproic Acid affects the expression of ITGB5 mRNA CTD PMID:23179753 , PMID:25979313 valproic acid decreases expression ISO RGD:1349145 6480464 Valproic Acid results in decreased expression of ITGB5 mRNA CTD PMID:26272509 , PMID:28001369 valproic acid multiple interactions ISO RGD:1349145 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ITGB5 mRNA CTD PMID:27188386 zoledronic acid decreases expression ISO RGD:1349145 6480464 zoledronic acid results in decreased expression of ITGB5 mRNA CTD PMID:24714768